Mass General Brigham Ventures
Corporate VCBoston · Seed–Series A
Investment thesis
Through its Artificial Intelligence and Digital Innovation Fund, Mass General Brigham Ventures backs venture-stage companies whose products and services advance the health system's strategic priorities, with a focus on artificial intelligence and digital innovation in healthcare.
Source: firm website, verified Aug 11, 2026.
What they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 12 dated
Abcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.
BiotechHealthtechNewton, US
John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Ryan Berry(Director)Donald McCarthy(Director)John Edwards(Director)Yajun Xu(Director)
BiotechBoston, US
David Allison(Director)Meredith Fisher(Director)Scott Rocklage(Executive Officer, Director)Roger Kitterman(Director)
Board seatMeredith FisherRoger Kitterman· per SEC Form D · $20M raise · filed Aug 2020
CodaMetrix builds AI-powered automation for medical coding within the healthcare revenue cycle, translating unstructured clinical data into reimbursement codes.
AI & Machine LearningDigital HealthHealthtechBoston, US
Hamid Tabatabaie(Director, Executive Officer, Promoter)Mark Pottle(Executive Officer)Tara Bradley(Executive Officer)Jim Whelan(Mr. Whelan is the Chief Revenue Officer of the Issuer.)Kevin Schmitt(Mr. Schmitt is the Chief Engineering Officer of the Issuer.)Jay Aslam(Mr. Aslam is the Chief Data Science Officer of the Issuer.)
Board seatRoger Kitterman· per SEC Form D · $15M raise · filed May 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Mass General Brigham Ventures invest at?
- Mass General Brigham Ventures invests at the Seed, Series A stages.
- What sectors does Mass General Brigham Ventures focus on?
- Mass General Brigham Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Mass General Brigham Ventures located?
- Mass General Brigham Ventures is headquartered in Boston, US.
Similar investors
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
Kaiser Permanente Ventures is the corporate venture capital arm investing in healthcare companies that address real needs and deliver value for patients, providers, healthcare delivery systems, and communities.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.